Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PIMAVANSERIN Cause Inability to afford medication? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Inability to afford medication have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.0% of all adverse event reports for PIMAVANSERIN.

8
Reports of Inability to afford medication with PIMAVANSERIN
0.0%
of all PIMAVANSERIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Inability to afford medication From PIMAVANSERIN?

Of the 8 reports.

Is Inability to afford medication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does PIMAVANSERIN Cause?

Hallucination (10,839) Death (9,352) Drug ineffective (5,545) Product dose omission issue (3,808) Confusional state (3,779) Fall (3,366) Delusion (2,421) Hallucination, visual (1,954) Gait disturbance (1,923) Parkinson's disease (1,918)

What Other Drugs Cause Inability to afford medication?

LISDEXAMFETAMINE DIMESYLATE (913) RIFAXIMIN (672) APIXABAN (479) BREXPIPRAZOLE (355) FLUTICASONE\SALMETEROL (323) ARIPIPRAZOLE (280) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (274) VIBEGRON (267) CERTOLIZUMAB PEGOL (238) SITAGLIPTIN (227)

Which PIMAVANSERIN Alternatives Have Lower Inability to afford medication Risk?

PIMAVANSERIN vs PIMECROLIMUS PIMAVANSERIN vs PIMOZIDE PIMAVANSERIN vs PINAVERIUM PIMAVANSERIN vs PINDOLOL PIMAVANSERIN vs PIOGLITAZONE

Related Pages

PIMAVANSERIN Full Profile All Inability to afford medication Reports All Drugs Causing Inability to afford medication PIMAVANSERIN Demographics